The move would add another barrier for parents who want to vaccinate healthy children ahead of the respiratory virus season.

US Government cuts to mRNA vaccine research could set technological advances, reduce access to therapies, and raise their costs.

The expedited approval of mpox vaccines is critical to addressing this public health emergency. Building on the practice in approving COVID-19 vaccines, this analysis investigates the regulatory ...